Loading...
Loading...
Application UK00918155525 · Registered
| Application Number | UK00918155525 |
| Status | Registered |
| Owner | Kite Pharma, Inc. |
| Filed | 2019-11-20 |
| Registered | 2020-03-06 |
| Renewal Due | 2029-11-20 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. XKARTUS is currently a registered UK trademark, with renewal due on 2029-11-20. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene therapy; biological preparations for the treatment of cancer.
Providing medical and healthcare information; providing medical information in the field of pharmaceuticals and cell therapy.
'XKARTUS' is a registered trademark on the UK IPO register, owned by Kite Pharma, Inc.. The application (UK00918155525) was filed on 20 November 2019 and registered on 6 March 2020. The registration is set to expire on 20 November 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Kilburn & Strode LLP.
UK trademark UK00918155525 for the mark 'XKARTUS' in Class 5, 44 is recorded on the UK IPO register as owned by Kite Pharma, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00918155525 for the mark 'XKARTUS' as registered.
UK trademark UK00918155525 for the mark 'XKARTUS' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for immunotherapy, including cell therapy and gene therapy; biological preparations for the treatment of cancer. | Class 44: Providing medical and healthcare information; providing medical information in the field of…
UK trademark UK00918155525 for the mark 'XKARTUS' was filed at the UK IPO on 20 November 2019 and registered on 6 March 2020.
UK trademark UK00918155525 for the mark 'XKARTUS' is currently recorded as valid until 20 November 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Kilburn & Strode LLP is listed as the attorney / representative of record for UK trademark UK00918155525 for the mark 'XKARTUS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "XKARTUS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| XKARTUSSame applicant | 88560325 | 606 | 2019-08-01 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.